ScoreWhy is Guizhou Yibai Pharmaceutical Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of -10.24% and Operating profit at -195.48% over the last 5 years
2
The company has declared Negative results for the last 6 consecutive quarters
- OPERATING CASH FLOW(Y) Lowest at CNY 90.91 MM
- INTEREST(Q) At CNY 7.28 MM has Grown at 234.02%
- CASH AND EQV(HY) Lowest at CNY 1,326.64 MM
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 8.68%, its profits have fallen by -74.1%
- At the current price, the company has a high dividend yield of 0
4
Underperformed the market in the last 1 year
- The stock has generated a return of 8.68% in the last 1 year, much lower than market (China Shanghai Composite) returns of 22.49%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Guizhou Yibai Pharmaceutical Co., Ltd. for you?
Medium Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Guizhou Yibai Pharmaceutical Co., Ltd.
-22.37%
0.67
31.86%
China Shanghai Composite
16.78%
1.58
14.20%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-13.49%
EBIT Growth (5y)
-180.25%
EBIT to Interest (avg)
4.25
Debt to EBITDA (avg)
0.78
Net Debt to Equity (avg)
0.17
Sales to Capital Employed (avg)
0.65
Tax Ratio
0.71%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
5.75%
ROE (avg)
4.72%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.23
EV to EBIT
-17.90
EV to EBITDA
-175.27
EV to Capital Employed
1.21
EV to Sales
1.67
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-6.75%
ROE (Latest)
-10.27%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend4What is working for the Company
NET PROFIT(HY)
Higher at CNY -141.26 MM
RAW MATERIAL COST(Y)
Fallen by -1.57% (YoY
-16What is not working for the Company
ROCE(HY)
Lowest at -15.08%
NET SALES(Q)
Lowest at CNY 358.84 MM
INVENTORY TURNOVER RATIO(HY)
Lowest at 1.32 times
Here's what is working for Guizhou Yibai Pharmaceutical Co., Ltd.
Net Profit
Higher at CNY -141.26 MM
than preceding 12 month period ended Mar 2026MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (CNY MM)
Raw Material Cost
Fallen by -1.57% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Guizhou Yibai Pharmaceutical Co., Ltd.
Net Sales
At CNY 358.84 MM has Fallen at -22.95%
over average net sales of the previous four periods of CNY 465.73 MMMOJO Watch
Near term sales trend is extremely negative
Net Sales (CNY MM)
Net Sales
Lowest at CNY 358.84 MM and Fallen
In each period in the last five periodsMOJO Watch
Near term sales trend is very negative
Net Sales (CNY MM)
Inventory Turnover Ratio
Lowest at 1.32 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
